Details of the Drug Formulaction

General Information of Drug Formulation (ID: F24249)

• Formulation Name: Terbinafine Hydrochloride eq 250mg base tablet
• Company: Cipla Usa ; Directrx; Preferred Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Terbinafine	(DMI6HUW)	Fungal infection	1F29-1F2F	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Hydrophobic colloidal silica	(E00285)	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Hypromellose	(E00634)	Not Available	Coating agent
Magnesium stearate	(E00208)	11177	lubricant